According to the Complaint, Adesto Technologies Corporation is a leading provider of application-specific semiconductors and embedded systems for the Industrial IoT .
Recent Security Class Actions
According to the Complaint, CenterState Bank Corporation operates as one of the leading Southeastern regional bank franchises.
According to the Complaint, Paysign, Inc. purports to provide prepaid card programs and processing services under the PaySign brand to corporations, government agencies, universities, and other organizations. The Company changed its name from 3PEA International Inc. to Paysign, Inc. on April 23, 2019.
According to the Complaint, Alpha and Omega Semiconductor Limited designs, develops, and supplies power semiconductors. It purports to have a portfolio of over 2,100 products that target high volume applications, including personal computers, LED lighting, battery packs, home appliances, and consumer and industrial motor controls.
According to the Complaint, Delphi Technologies PLC is a global provider of propulsion technologies.
According to the Complaint, Front Yard Residential Corporation is an industry leader in providing quality, affordable rental homes.
AMTD IDEA Group American Depositary Shares each representing one Class A Ordinary Share (NYSE: AMTD)
According to the Complaint, TD Ameritrade provides investing services and education to approximately 12 million client accounts totaling approximately $1.3 trillion in assets, and custodial services to more than 7,000 registered investment advisors.
According to the Complaint, LogicBio Therapeutics, Inc. purports to be a genome editing company, focused on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The Company’s lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia (“MMA”), a life-threatening disease that presents at birth.
According to the Complaint, Forescout Technologies, Inc. delivers device visibility and control to enable enterprises and government agencies to gain complete situational awareness of their environment and orchestrate action.
According to the Complaint, Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on technology licensed from Stanford University.
